In February 2010, Management Forum held a 3-day seminar on how to develop drugs for companion animals. With a comprehensive programme the speakers delivered valuable information on how to develop these medicines and how to manage the various stages, timetable and budgets involved in the process.
Everyone involved in companion animal medicines must be aware of the main stages in the development programme, and be able to relate their responsibilities to the expertise and needs of the scientists and commercial members of the team.
This course was designed to demonstrate how pharmaceutical, pharmacological, toxicological and clinical investigations and regulatory management are brought together in the development programme. It took the participants through all the stages in the development of a veterinary medicinal product for companion animals, for which a marketing authorisation is sought in the European Union. Presentations covered pharmaceutical and process development, toxicological, pharmacological, safety risk assessments, clinical development, and EU regulatory submissions. An important part of the course was devoted to working on case studies in the workshop sessions.
If you would like further information about this course which will be run again early in 2011, please contact andrea.james@management-forum.co.uk
Click here to go to the conference webpage.
On 25th May, the World Organisation for Animal Health (OIE) published an alarming report on the impact of climate change for the animal health.
The results of this report, which was conducted in 126 OIE’s member countries, shows that 71% of them feel extremely concerned about the expected impact of climate change on emerging and re-emerging diseases. 58% were able to identify at least one emerging or re-emerging desease on their territory, desease which can be associated to climate change.
The 3 most frequently deseases mentionned by the OIE are the bluetongue, the Rift Valley fever and the West Nile fever.
The aim is now to provide professionnals of the Animal Health industry with tools to fight these new problems.
“This is a reality we cannot ignore and we must help veterinary services throughout the world to equip themselves with systems that comply with international standards of good governance” said Dr Bernard Vallat, Director General of the OIE.
We are please to announce that after 25 years of successfully run conferences in the UK, Management Forum is ready to enter the American market.
This will be the opportunity for you to attend the Medical Device and the Animal Health Autumn Schools. These events will take place in Boston at the end of September 2009.
The Medical Device Autumn School will focus on the market access for medical devices in Europe with reference to the US FDA requirements and the differences between Europe and the USA. In other words, you will learn everything from concept to market.
The Animal Health Autumn School will allow you to gain a comprehensive understanding of the entire veterinary drug development programme in the EU and USA.
To learn more about these events, please:
The Animal Health industry faces enormous challenges as the 21st century gathers momentum, regulation, in the UK, EU and the USA is becoming increasingly more complex with additional issues of compliance to consider, such as increased requirements for pharmacovigilance and risk management. Do you find this a hinderance or a help?
Stay ahead looking at our Animal Health agenda.
Management Forum’s events schedule is designed to provide a unique educational platform to understand the regulatory, clinical and pharmacovigilance requirements, and to discover best practices for the development of veterinary pharmaceutical and biological medicines.
Click here to visit our Animal Health event WebPage.
Recent Comments